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Available online 6 April 2016AbstractA convenient method for the synthesis of new series of N-acylsulfonamide containing oxazolidin-2-one moiety starting from
chlorosulfonyl isocyanate and chiral oxazolidinones in two steps (carbamoylation and sulfamoylation), is described. The starting
oxazolidinones were obtained in two steps starting from amino acids by reduction with NaBH4 then cyclization in the presence of
carbonate diethyl. The synthesis of N-acylsulfonamide oxazolidin-2-ones derivatives has been carried out in excellent isolated
yields. The structures of all synthesized compounds were unambiguously confirmed by usual spectroscopic methods 1H NMR, 13C
NMR, IR, EA and MS.
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Oxazolidinones containing sulfonamides moiety
have attracted obvious attention due to their significant
biological properties and their role as pharmacophores
[1]. Studies have shown that oxazolidinone heterocy-
cles were used as antibacterial [2], inhibitors of
monoamine oxidase [3], cytokine modulators [4],
sigma receptors [5], pschyotropics [6], antiallergy
agents [7], antibiotics [8], intermediates in the syn-
thesis of renin inhibitors [9], b-lactam and macrolide* Corresponding author.
E-mail addresses: mberredjem@yahoo.fr, malika.berredjem@
univ-annaba.org (M. Berredjem).
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the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/antibiotics [10], immunesuppressants [11], and in
many other applications [12].
It is revealed that sulfonamide moiety can enhance
largely the activity of antibacterial agents especially
against both Gram-positive and Gram-negative bacteria
[13,14].Basedon this fact, a positive effect of sulfonamide
moieties on the activity of oxazolidinone was anticipated.
In the literature new oxazolidin-2-ones containing
sulfonamide moiety have been described and have
interesting biological properties. These compounds
were first synthesized for their utility for treating plant
diseases such as Sulfoxide1. Antibacterial properties
were discovered six years later, specifically, sulfon-
amide 2 exhibited modest efficacy against several
strains of bacteria [15] Fig. 1.n behalf of University of Kerbala. This is an open access article under
4.0/).
Fig. 1. Structures of oxazolidin-2-ones with sulfonamide group.
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3 derivatives with important pharmaceutical activities
such as antibacterial againt both Gram-positive and
Gram-negative bacteria were describe [16]. Recently,
Kamal. A et al. synthesized novel oxazolidino-
sulfonamide 4 and evaluated their antimicrobial ac-
tivity. This compound exhibited significant activity,
with a MIC value of 2.0e6.0 mg/ml against a panel of
Gram-positive and Gram-negative bacteria also
showed activity against Candida albicans, with a MIC
value of 4.0 mg/mL [17].
Thus, as a supplement of the work previously pub-
lished by our group and as part in another ongoing
research work aimed at the synthesis of novel product
with potential antibacterial activities, the present study
also propose a novel approach for the synthesis of new
N-acylsulfonamide oxazolidinones derivatives.
2. Results and discussion
N-acylsulfonamide oxazolidin-2-ones 1e8e were
easily prepared in good yield (77e86%), using
chlorosulfonyl isocyanate (CSI) that has been shown to
be a versatile reagent for the introduction of the sul-
fonamide moiety [18e22]. The starting oxazolidinones
1e3c were obtained in two steps starting from amino
acids by reduction with NaBH4 then cyclization in the
presence of carbonate diethyl.
Chlorosulfonyl isocyanate is known to react with
active hydrogen containing compounds at both the
isocyanate and the sulfonyl chloride functionalities.
Generally, this reactivity with amines is nonspecific
and therefore any useful products must be the reaction
product of the same amine with both functionalities.
However, with hydroxyl containing compounds the
isocyanate group reacts first and cleanly at tempera-
tures below about 0 C so that a sequential reaction of
a stoichiometric amount of a hydroxy containingcompound with the isocyanate, followed by reaction of
an amine with the chlorosulfonyl group, allows for-
mation of carboxylsulfamide [23,24].
In our case, the synthesis of compounds 1e8e was
achieved by carbamoylation reaction with secondary
amines starting from chiral oxazolidinone 1-8c.
Carbamoylation: The various oxazolidinones reac-
ted smoothly with chlorosulfonyl isocyanate in the
presence of dichloromethane to easily give carbamate.
Sulfamoylation: The condensation of the carbamate
chlorosulfonyl oxazolidinone 1-3d with commercially
available corresponding primary or secondary amines
in the presence of triethylamine at 0 C afford
substituted N-acylsulfonamide oxazolidin-2-ones de-
rivatives in good yields (Scheme 1).
The structures of all synthesized compounds were
unambiguously confirmed by usual spectroscopic
methods 1HNMR, 13C NMR, MS, EA and IR.
The results of these studies are presented in Table 1.
3. Experimental
3.1. General
All chemicals and solvents were purchased from
common commercial sources and were used as
received without any further purification. All reactions
were monitored by TLC on silica Merck 60 F254
percolated aluminum plates and were developed by
spraying with ninhydrin solution. Column chromatog-
raphy was performed with Merck silica gel
(230e400 mesh). Proton nuclear magnetic resonance
(1H NMR) spectra were recorded on a Bru¨cker spec-
trometer at 400 MHz. Chemical shifts is reported in
d units (ppm) with TMS as reference (d 0.00). All
coupling constants (J) are reported in Hertz. Multi-
plicity is indicated by one or more of the following: s
(singlet), d (doublet), t (triplet), q (quartet), m
Scheme 1. Synthesis of new N-acylsulfonamides containing oxazolidin-2-one moiety.
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NMR) spectra were recorded on a Bru¨cker at
100 MHz. Chemical shifts are reported in d units (ppm)
relative to CDCl3or DMSOd6 (d 77.0 and 39.0e40.0).
Infrared spectra were recorded on a SHIMADZU FT-
IR 8000 spectrometer. Elemental analyses were
recorded on a EURO E.A 3700. Melting points were
recorded on a Bu¨chi B-545 apparatus in open capillary
tubes.
3.2. General procedure for the synthesis of N-acyl-
sulfonamide oxazolidinones
A solution of oxazolidinone (1 equiv) in anhydrous
CH2Cl2 (5 ml) was added to a stirring solution of
chlorosulfonyl isocyanate (CSI) (1.1 equiv) in (5 ml) of
anhydrous CH2Cl2 at 0
C dropwise over a period of
30 min. The resulting solution was transferred to a
mixture of primary or secondary amine (1.0 equiv) in
CH2Cl2 (5 ml) in the presence of triethylamine
(1.3 equiv). The solution was stirred at 0 C for less
than 1.5 h. The reaction mixture was washed with HCl
0.1 N and water, and the organic layer was dried over
anhydrous sodium sulfate, filtered and concentrated in
vacuo. The residue was purified by silica gel chroma-
tography to give carboxylsulfamides in good yields.
3.2.1. (S)-4-benzyl-2-oxo-N-(N-phenylsulfamoyl)oxa-
zolidine-3-carboxamide (Table 1, Entry 1e)
White powder (80%); m.p. 132e134 C. IR (KBr,
cm1): 3296.20, 3284.19, 1741.06, 1357.57, 1160.90,
1028.66; 1H NMR (400 MHz, CDCl3): d ¼ 2.54e2.61
(dd, 1H, J1 ¼ 8, J2 ¼ 16 Hz, H2eCH*), 2.64e2.71
(dd, 1H, J1 ¼ 8, J2 ¼ 16 Hz, CH2eCH*), 3.79e3.88
(m, 2H, CH2eO), 4.10e4.17 (m, 1H, CH*-N), 6.27 (s,
1H, NHeSO2), 6.93e7.08 (m, 10H, HeAr), 7.77 (s,
1H, NHeC]O) ppm; 13C NMR (100 MHz, CDCl3):d ¼ 41.02, 53.71, 69.57, 119.84, 120.66, 121.53,
127.02, 129.06, 129.25, 135.88, 136.37, 151.68,
160.21 ppm; Ms (m/z): 376.1 [Mþ1]; Anal. Calc. for
C17H17N3O5S: C, 54.39; H, 4.56; N, 11.19; S, 8.54;
Found: C, 41.47; H, 4.63; N, 11.26; S, 8.60.
3.2.2. (S)-4-benzyl-N-(morpholinosulfonyl)-2-
oxooxazolidine-3-carboxamide (Table 1, Entry 2e)
White powder (78%); m.p. 144e146 C. IR (KBr,
cm1): 3305.15, 17135.23, 1691.15, 1381.56, 1167.80,
1023.15; 1H NMR (400 MHz, CDCl3): d ¼ 2.51e2.57
(dd, 1H, J1¼ 8, J2¼ 16Hz, CH2eCH*), 2.60e2.69 (dd,
1H, J1¼ 8, J2¼ 16Hz,CH2eCH*), 3.41e3.57 (m, 4H, 2
CH2eN), 3.67e3.77 (m, 4H, 2 CH2eO), 3.77e3.85 (m,
2H, CH2eO), 4.05e4.12 (m, 1H, CH*-N), 7.03e7.15
(m, 5H,HeAr), 8.54 (s, 1H,NHeC]O)ppm; 13CNMR
(100 MHz, CDCl3): d ¼ 40.19, 51.98, 54.56, 69.57,
70.45, 122.20, 123.73, 128.01, 128.76, 131.60, 132.25,
151.91, 159.67ppm;Ms (m/z): 371.1 [Mþ1];Anal.Calc.
for C15H19N3O6S: C, 48.77; H, 5.18; N, 11.38; S, 8.68;
Found: C, 48.85; H, 5.14; N, 11.25; S, 8.62.
3.2.3. (S)-4-benzyl-2-oxo-N-((4-phenylpiperazin-1-yl)
sulfonyl)oxazolidine-3-carboxamide (Table 1, Entry
3e)
White powder (77%); m.p. 139e141 C. IR (KBr,
cm1): 3298.74, 1718.46, 1376.12, 1161.45, 1047.86;
1H NMR (400 MHz, CDCl3): d ¼ 2.57e2.63 (dd, 1H,
J1 ¼ 8, J2 ¼ 16 Hz, CH2eCH*), 2.68e2.76 (dd, 1H,
J1 ¼ 8, J2 ¼ 16 Hz, CH2eCH*), 3.21e3.44 (m, 4H, 2
CH2eN), 3.48e3.57 (m, 4H, 2 CH2eN), 3.77e3.85
(m, 2H, CH2eO), 4.09e4.15 (m, 1H, CH*-N),
6.91e7.43 (m, 10H, HeAr), 9.12 (s, 1H, NHeC]O)
ppm; 13C NMR (100 MHz, CDCl3): d ¼ 41.01, 50.75,
53.94, 57.80, 68.87, 118.20, 119.56, 121.22, 123.54,
125.86, 128.79, 129.94, 132.40, 133.78, 135.20,
152.09, 161.64 ppm; Ms (m/z): 445.20 [Mþ1]; Anal.
Table 1
Synthesis of N-acylsulfonamide-oxazolidin-2-oneSs by carbamoylation and sulfamoylation reaction.
Entry Substrat Compound M.P C Yields %
1e 132e134 80
2e 144e146 78
3e 139e141 77
4e 143e145 79
5e 136e138 83
6e 140e142 86
7e 119e121 78
(continued on next page)
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Table 1 (continued)
Entry Substrat Compound M.P C Yields %
8e 115e117 81
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7.21; Found: C, 56.81; H, 5.48; N, 12.53; S, 7.27.
3.2.4. (S)-4-isopropyl-N-(morpholinosulfonyl)-2-
oxooxazolidine-3-carboxamide (Table 1, Entry 4e)
White powder (79%); m.p. 143e145 C. IR (KBr,
cm1): 3285.07, 1741.43, 1357.06, 1161.20, 1029.94;
1H NMR (400 MHz, DMSO d6): d ¼ 0.91 (d, 3H,
J ¼ 12 Hz, CH3eCH), 0.95 (d, 3H, J ¼ 11.80 Hz,
CH3eCH), 1.67 (m, 1H, CH-isop), 2.42e2.48 (m, 1H,
CH*-N), 3.41e3.42 (m, 4H, 2 CH2eN), 3.74e3.79
(m, 4H, 2 CH2eO), 3.36e3.44 (dd, 2H, J1 ¼ 6.00,
J2 ¼ 12.00 Hz,CH2eCH*), 10.35 (s, 1H, NHeC]O)
ppm; 13C NMR (100 MHz, DMSO d6): d ¼ 14.66,
17.71, 17.89, 18.15, 28.61, 46.80, 58.62, 64.41, 66.40,
147.56, 155.67; Ms (m/z): 322.1 [Mþ1]; Anal. Calc.
for C11H19N3O6S: C, 41.11; H, 5.96; N, 13.08; S, 9.98;
Found: C, 41.17; H, 5.92; N, 13.02; S, 9.94.
3.2.5. (S)-4-isopropyl-2-oxo-N-((4-phenylpiperazin-1-
yl)sulfonyl)oxazolidine-3-carboxamide (Table 1, Entry
5e)
White powder (83%); m.p. 136e138 C. IR (KBr,
cm1): 3258.19, 1750.35, 1725.23, 1344.82, 1154.17,
1030.45; 1H NMR (400 MHz, DMSO d6): d ¼ 0.80 (t,
3H, J ¼ 5.62 Hz, CH3eCH), 0.84 (t, 1H, J ¼ 5.64 Hz,
CH3eCH), 1.57e1.61 (m, 1H, CHisop), 2.15e2.20 (m,
1H, CH*), 3.30e3.33 (m, 4H, 2 CH2eN), 3.40e3.54
(m, 4H, 2 CH2eN), 3.96e4.42 (td, 2H, J1 ¼ 4.80,
J2 ¼ 7.56, J3 ¼ 9.20 Hz, CH2eO), 7.20e7.25 (m,5,
HeAr), 10.47 (s, 1H, NHeC]O) ppm; 13C NMR
(100 MHz, DMSO): d ¼ 14.61, 17.15, 28.41, 32.52,
46.09, 48.07, 57.18, 57.93, 64.56, 115.58, 116.12,
119.61, 119.32, 128.97, 147.20, 150.40, 158.96 ppm;
Ms (m/z): 397.2 [Mþ1]; Anal. Calc. for C17H24N4O5S:
C, 51.50; H, 6.10; N, 14.13; S, 8.09; Found: C, 51.45;
H, 6.17; N, 14.16; S, 8.15.
4. Conclusion
In summary, we have developed a convenient and
efficient route for the synthesis of novel N-acylsulfona-
mide oxazolidinones derived fromchiral oxazolidinones.The synthesized compounds were obtained in good yield
starting from the carbamoylation of chlorosulfonyl iso-
cyanate with oxazolidinone then sulfamoylation by
various amines. This synthesis has many advantages like
no side reactions, facile isolation of products, and no
temperature.
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